HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Clinical Study Shows Vista.ai Significantly Reduces Cardiac MRI Scan Time
The findings show that Vista.ai’s AI-guided image acquisition software improves cardiac MRI (CMR) scan times and achieves high adoption rates by hospital imaging staff. Dr. Kwong will discuss the learnings and implications of the study at an interactive breakfast symposium at 7:20 a.m. PST on Jan. 27, 2023, at the SCMR Scientific Sessions in San Diego.
MedAlliance Leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study
SELUTION SLR is commercially available in Europe, Asia, the Middle East, and the Americas (outside USA) and most other countries where the CE Mark is recognized. Over 10,000 units have been used for patient treatments in routine clinical practice or as part of coronary clinical trials. Centres interested in participating in this study, please contact MedAlliance.
VEXAS Syndrome Study Offers First Glimpse of How Many Suffer From Previously Unknown Illness
In the new VEXAS syndrome study, publishing in the Journal of the American Medical Association (JAMA) online Jan. 24, researchers analyzed the electronic health records of 163,096 mostly white men and women in Pennsylvania who agreed to have their blood DNA screened for signs of genetic disease. Twelve were found to have the UBA1 mutation, with all experiencing VEXAS symptoms.
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress
David Jenkins, Ra Medical Systems Executive Chairman. “All four abstracts with VIVO clinical data submitted by leading physicians to the Congress were accepted for presentation following an extensive peer-review process. To have one-hundred percent acceptance of submitted abstracts is rare and I believe indicative of the positive impact VIVO is having on ventricular ablation procedures. We view this recognition as a major milestone in gaining clinical acceptance by both EP thought leaders and the larger medical community.”
New Study Shows Vasc-Alert Surveillance Technology Successfully Predicts Vascular Access Blockages in Dialysis Patients
Vasc-Alert, a pioneer in vascular access surveillance, today announced the publication of a study in the Journal of Vascular Access validating its Vasc-Alert surveillance...
Delcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiology
Updated results from the CHOPIN Phase 1b Trial in seven patients with advanced uveal melanoma treated with CHEMOSAT and ipilimumab plus nivolumab show a Median PFS of 29.1 months
Inflammation Levels Tied to Severity of Blood Cancer
Severe inflammation weakens the body’s ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study shows.
Grifols Achieves Positive Topline Results from Phase 3b Study of its Fibrin Sealant to Treat Surgical Bleeding in Pediatric Patients
Having met all primary and secondary endpoints, the study is expected to facilitate regulatory approval to expand the use of the FS-based biosurgery treatment, currently indicated for adults, to children and adolescents as well notes Grifols.
Baylor Scott & White Research Institute, TGen and OncoHost Announce New Research Study to Analyze Resistance Mechanisms in Lung Canc
OncoHost notes this multi-year study is one of the most extensive, comprehensive, and prospective evaluations of cancer dynamics and resistance mechanisms the industry has seen.
